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SObjective: To assess lung function, gas exchange, exercise capacity, and right-sided heart hemodynamics,
including pulmonary artery pressure, in patients long term after pneumonectomy.
Methods: Among 523 consecutive patients who underwent pneumonectomy for lung cancer between January
1992 and September 2001, 117 were alive in 2006 and 100 were included in the study. During a 1-day period,
each patient had complete medical history, chest radiographs, pulmonary function studies, resting arterial blood
gas analysis, 6-minute walk test, and Doppler echocardiography.
Results:Most patients (N ¼ 73) had no or only minimal dyspnea. On the basis of predicted values, functional
losses in forced expiratory volume in 1 second and forced vital capacity were 38%  18% and 31%  24%,
respectively, and carbon monoxide diffusing capacity decreased by 31%  18%. There was a significant cor-
relation between preoperative and postoperative forced expiratory volume in 1 second (P<.01), and more hy-
perinflation was associated with better lung function (P<.01 for forced expiratory volume in 1 second). Gas
exchangewas normal at rest (PAO2¼ 88 10mmHg; PACO2¼ 42 3mmHg), and exercise tolerance (6-minute
walk) was also normal (83%  17% of predicted values). Thirty-two patients had some degree of pulmonary
hypertension, but in most of those cases, it was mild to moderate (mean systolic pressure of 36 9 mm Hg) and
not associated with significant differences in lung function (P ¼ .57 for forced expiratory volume in 1 second),
gas exchange (P ¼ .08), and exercise capacity (P ¼ .66).
Conclusions: These findings indicate that despite worsening of lung function by approximately 30% after pneu-
monectomy, most patients can adjust to living with only 1 lung. Pulmonary hypertension is uncommon and in
most cases only mild to moderate. (J Thorac Cardiovasc Surg 2011;141:7-15)Ever sinceGraham and Singer1 performed the first successful
en bloc pneumonectomy for lung cancer in April 1933 and
Archibald2 performed the first successful hilar dissection
pneumonectomy in July 1933 (Figure 1), a number of histor-
ical reports3-11 have attempted to look at the cardiopulmonary
adjustments that follow the operation to define long-term
functional status. The pertinence of these earlier contribu-
tions is, however, limited because many of them were per-
formed in patients who had their pneumonectomy for
benign diseases (predominantly tuberculosis) or were per-
formed in a small number of patients, and often the time in-
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The Journal of Thoracic andThus, several beliefs have persisted over the years, such as
(1) marked hyperinflation of the residual lungmay be associ-
ated with poor lung function, (2) most patients have elevated
systolic pulmonary artery pressure (SPAP), and (3) most
patients have poor exercise capacity.
The Pneumonectomy Project was designed to be a de-
scriptive study with a primary objective of evaluating lung
function, gas exchange, exercise capacity, and right-sided
heart hemodynamics in long-term pneumonectomy cases
through the use of simple and reproducible tests of cardio-
respiratory function.PATIENTS AND METHODS
Study Population and Patient Selection
All patients who underwent pneumonectomy for lung cancer between
January 1992 and March 2001 and were still alive in March 2006 (5-year
minimum follow-up) were recruited for the study. Patients were excluded
if they were not disease-free at the time of the study, had a cognitive deficit,
lived too far from the study center, or refused to participate. For patients
who died during the interval between pneumonectomy and study period,
the dates and causes of death were obtained from in-hospital medical re-
cords or from the Province of Quebec population registry. Causes of death
were classified as cancer deaths, which included postoperative deaths,
deaths related to cardiopulmonary events, or deaths from other causes.
The protocol received approval from the hospital institutional review
board, and written consent was obtained from all patients who participated
in the study.Cardiovascular Surgery c Volume 141, Number 1 7
Abbreviations and Acronyms
ATS ¼ American Thoracic Society
DLCO ¼ carbon monoxide diffusing capacity
FEV1 ¼ forced expiratory volume in 1 second
FVC ¼ forced vital capacity
6-MWT ¼ 6-minute walk test
SPAP ¼ systolic pulmonary artery pressure
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Under the supervision of one of the investigators (P.U.) and a research
nurse, each study patient underwent complete medical history and physical
examination, standard posteroanterior and lateral chest radiographs, pul-
monary function tests, resting arterial blood gas analysis, 6-minute walk
test (6-MWT), and Doppler echocardiography during a 1-day period. All
patients also completed the respiratory disease questionnaire12 recommen-
ded by the American Thoracic Society (ATS).Pulmonary Function Studies, Arterial Blood Gas
Analysis, and 6-Minute Walk Test
Pulmonary function studies were performed according to the European
Respiratory Society recommendations.13-15 Lung volumes were measured
by plethysmography using a constant-volume chamber. Carbon monoxide
diffusing capacity (DLCO) was measured by the single-breath method
(Vmax Spectra 22D, Sensor Medico, Yorba Linda, CA). Individual results
were compared with predicted values. Arterial blood for gas analysis wasFIGURE 1. Operative photograph taken during the first successful hilar dissec
Royal Victoria Hospital in Montreal. The operation was a left pneumonectomy
lobe. Dr Archibald is on the anesthetist’s left and to his left is Dr Norman Beth
operation but later died of recurrent disease. Photograph from the BethuneMem
with the permission of Parks Canada, National Photo Collection.
8 The Journal of Thoracic and Cardiovascular Surgerobtained from the radial artery after the patient had a 10-minute rest in
the sitting position and was not receiving supplemental oxygen; samples
were immediately analyzed. A non-encouraged 6-MWT was performed
under the supervision of a research assistant according to the guidelines
of the ATS,16 and individual 6-minute walked distances were compared
with predicted values.17
Echocardiography
Complete 2-dimensional and Doppler ultrasound examinations (Phillips
SONOS 5500; Phillips Medical Systems, Andover, Mass) were performed
by the same cardiologist (S.B.) blinded to patients’ functional capacity and
lung function. Recordings were then analyzed through the use of an offline
quantification system. Measurements were made on 3 representative beats,
and results were averaged. Maximal tricuspid regurgitant jet velocity, right
ventricular index of myocardial performance, left ventricular ejection frac-
tion, cardiac output, valvular abnormalities, mitral velocity, and left ven-
tricular filling pressures were also measured. The SPAP was estimated
by using the maximal tricuspid regurgitant jet velocity, according to the
Bernoulli equation, and results were compared with reference values ac-
cording to age.18
Imaging
Contralateral lung hyperinflation was assessed on a posteroanterior
chest radiography. A horizontal straight line was drawn from the middle
of the spine toward the chest wall at the level of maximal contralateral
lung hyperinflation. The importance of hyperinflation was defined as the
ratio of the maximal distance from the middle of the spine to the extremity
of the lung hyperinflation over the maximal distance from the middle of the
spine to the chest wall. These evaluations were performed independently
by 2 investigators (S.F., P.U.), and obtained values were averaged.tion pneumonectomy performed in July 1933 by Edward Archibald at the
performed through an anterolateral incision for a sarcoma of the left upper
une. Facing Dr Archibald is Dr Arthur Vineberg. The patient survived the
orial House National Historic site of Canada, Parks Canada, and reproduced
y c January 2011
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Values are reported as means  standard deviation unless otherwise
specified. The Kaplan–Meier method was used to estimate overall survival
after surgery. The date of surgery was the starting point to determine the
follow-up duration. The cutoff date was the day of evaluation. Patients ex-
cluded from the protocol were censored as of March 1, 2006. Comparisons
between patients with left and right pneumonectomy and between patients
with or without pulmonary hypertension were performed using paired t test
because all variables were normally distributed. Nonparametric variables
were compared using the chi-square test. Pearson’s correlation coefficients
were used to evaluate relationships among postoperative lung function,
pulmonary artery pressure, and demographics. The relationship between
patients’ symptoms as assessed by the ATS dyspnea questionnaire and ob-
jective functional status (eg, FEV1) was evaluated using analysis of vari-
ance. Mean postoperative FEV1 according to the level of hyperinflation
were compared using analysis of variance followed by Fisher’s least signif-
icance difference. Data were analyzed using StatView v5.0 (SAS Institute,
Cary, NC).RESULTS
During a 9-year period, 523 consecutive pneumonecto-
mies (Figure 2)were performed for lung cancer at the Institut
Universitaire de Cardiologie et de Pneumologie de Quebec
and 406 of those patients died during the follow-up period,523 consecutive pne
for lung cancer 
Year 20
117 patients alive 
(22.4%) 
100 patients 
Eligible 
for study 
17 patients 
excluded 
from study 
Reason for
exclusion (N)
Not disease-free : 5 
Cognitive deficit :  5 
Distance from 
study center : 4 
Refusal :  3 
FIGURE 2. Pneumonectomy Project: re
The Journal of Thoracic andwhich began the day of surgery. These include 31 operative
deaths (operative mortality of 5.9%) and 318 patients who
later died of cancer recurrence, for a total of 349 cancer-
related deaths. An additional 26 patients died of cardiopul-
monary causes, and for the most part, these were cardiac
events. For the entire cohort (N ¼ 523), 5-year survival
was 31.4% and mean survival time was 4.1  4.2 years
(Figure 3).
Of the 117 patients still alive in 2006, 17 were excluded
from study because they were not disease-free at the time of
study (N¼ 5), had a cognitive deficit (N¼ 5), lived at a dis-
tance from the study center (N¼ 4), or refused to participate
(N ¼ 3). The final cohort thus comprised 100 patients, and
their characteristics are shown in Table 1.
Some 91% of patients either stopped smoking after sur-
gery or never smoked, and 45% had regular employment
at the time of study. Fifty-two patients underwent a left pneu-
monectomy, and 48 patients underwent a right pneumonec-
tomy; most of these were extended operations (68%),
usually intrapericardial division of pulmonary blood vessels.
Themajority (63%) of patients had tumors of squamous his-
tology, and 5 patients were not given a pTNM stage becauseumonectomies 
(1992-2001) 
06 
406 patients dead 
(77.6%) 
Causes of death (N, %)
Cancer-related :  349 (86%) 
Cardiorespiratory :  26 (6%) 
Others :  31 (8%) 
cruitment and exclusion from study.
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FIGURE 3. Kaplan–Meier estimates of survival in 523 patients after
pneumonectomy for lung cancer.
TABLE 1. Characteristics of the 100 patients included in the study
population
General characteristics
Study population
n ¼ 100
Excluded patients
n ¼ 423
Age
At operation* 59  10 y 62  11 y
At time of study 68  10 y N/A
Gender
Female 23 125 (30%)
Male 77 298 (70%)
Currently smoking
Yes 9 N/A
No 91 N/A
Currently employed
Yes 45 N/A
No 55 N/A
Operation and cancer characteristics
Side of pneumonectomy
Left 52 205 (48%)
Right 48 218 (52%)
Type of pneumonectomy
Simple 32 125 (30%)
Extended 68 298 (70%)
Histology of carcinoma*
Squamous 63 205 (48%)
Non-squamous 37 218 (52%)
pTNM stagey (N ¼ 95) (N ¼ 399)
Stage 1 18 (19%) 56 (14%)
Stage 2 35 (37%) 126 (30%)
Stage 3 42 (44%) 217 (51%)
NA, Not available. *P¼ .01; all other P values>.15. ySixth edition of the TNM clas-
sification.
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Sthe pneumonectomy had been done for local recurrence of
a previously resected carcinoma (completion pneumonec-
tomy) (N¼ 4) or for metastatic disease (N¼ 1). Ten patients
received chemotherapy, mostly induction chemotherapy
(N ¼ 7), and 7 patients received adjuvant postoperative ra-
diotherapy.
Compared with the 423 patients who died or were ex-
cluded, the recruited patients were slightly younger and
more likely to have non-squamous histology and advanced
tumors (Table 1) but had similar FEV1 (86%  18% vs
81%  16% of predicted, P ¼ .07), FVC (86%  19% vs
83%  15% of predicted, P ¼ .15), and DLCO (87% 
20% vs 82%  27% of predicted, P ¼ .25). A similar pro-
portion of patients received chemotherapy (34/423, 8%) and
adjuvant postoperative radiotherapy (19/423, 4.5%).Effect of Pneumonectomy on Lung Function
Most patients (97%) had no (N¼ 26) or mild (N¼ 47) to
moderate (N ¼ 24) dyspnea (ATS grades 0–2), and 3 sub-
jects had severe dyspnea (ATS grade 3) characterized by
having to stop for breath after walking approximately 100
yards or a few minutes on the level. This subjective assess-
ment of dyspnea severity was associated with a progressive
decline in 6-minute walked distance and a progressive in-
crease in patients’ age from dyspnea grade 0–1 to grade 3
(from 457  71 m to 250  96 m and from 64  12 years
to 76  5 years, respectively, both P< .01). Conversely,
dyspnea was not related to time since surgery, postoperative
FEV1, or pulmonary artery pressure (all P>.20).
Pre- and post-spirometric values are shown in Table 2.
Functional percentage (of predicted values) losses in forced
expiratory volume in1 second (FEV1) and forcedvital capac-
ity (FVC) were 30% 22% and 14% 30%, respectively.
There was a significant correlation between preoperative
and postoperative FEV1, although a wide range of variance10 The Journal of Thoracic and Cardiovascular Surgeexisted between subjects (Figure 4). Postoperative FEV1
(percent of predicted) was not related to time since surgery
(r¼0.14,P¼ .18). Residual volume and total lung capacity
were greater than predicted for a patient with 1 lung, and
these changes are in keepingwith overdistention of the resid-
ual lung. With respect to hyperinflation, there was a signifi-
cant positive correlation between more hyperinflation, as
assessed by chest radiograph and better postoperative
FEV1 (Figure 5).
Although resting DLCO was reduced by 31%  18% of
predicted value for 2 lungs, it remained in the high range
(58%  12%) of what would be expected from a single
lung. Resting arterial PAO2 was normal (88  10 mm Hg),
and there was no evidence of CO2 retention (PACO2 ¼ 42 
3 mm Hg). The results of the 6-MWT show that most pa-
tients had relatively normal exercise tolerance (83% 
17% of predicted values), with only 19 of 91 patients having
abnormal 6-MWTresults, that is 153 and 139m less than the
expected normal values for men and women.17 Other than
for losses in expiratory lung volumes (FVC, FEV1), which
were higher after right pneumonectomy than after left pneu-
monectomy, therewere no significant differences in all otherry c January 2011
TABLE 2. Effect of pneumonectomy on lung function
Right pneumonectomy Left pneumonectomy Overall
Preoperative Postoperative
Relative
change (%) Preoperative Postoperative
Relative
change (%) Preoperative Postoperative
Relative
change (%)
Age at study (N ¼ 100) 57  10 67  11 61  9 69  8 59  10 67  11
Lung volumes (N ¼ 97)
FEV1 (liters) 2.51  0.66 1.38  0.40 44  16 2.44  0.65 1.53  0.37* 34  21y 2.47  0.65 1.46  0.39 38  19
FEV1 (% of predicted) 84  19 52  15 36  17 88  18 63  16y 25  24* 86  18 58  16 30  22
FVC (liters) 3.61  0.98 2.14  0.65 38  21 3.36  0.99 2.41  0.65* 25  24y 3.48  0.99 2.28  0.66 31  24
FVC (% of predicted) 87  18 64  19 25  23 85  19 78  19y 5  32y 86  19 71  20 14  30
FEV1/FVC (%) 71  17 65  9 7  16 74  9 65  10 11  13 73  13 65  10 9  15
TLC (% of predicted) 58  13 69  13y 64  14
RV (% of predicted) 56  13 65  15y 61  15
RV/TLC (%) 38  7 39  7 39  7
Hyperinflation (%)
(N ¼ 97)
47  29 59  29* 53  29
Gas exchange
DLCO (% of predicted)
(N ¼ 78)
89  19 55  11 34  15 85  21 60  12 29  19 87  20 58  12 31  18
PAO2, mm Hg (N ¼ 99) 87  10 89  9 88  10
PACO2, mm Hg (N ¼ 99) 42  3 41  4 42  3
Exercise capacity (N ¼ 91)
6MWD (m) 401  98 400  77 400  87
6MWD (% of predicted) 81  17 84  16 83  17
FEV1, Forced expiratory volume in 1 second; FVC, forced vital capacity; RV, residual volume; TLC, total lung capacity; DLCO, carbon monoxide diffusing capacity; 6 MWD,
6-minute walk distance. *P<.05. yP<.01 compared with right pneumonectomy.
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Sparameters of lung function whether the patient had a right
or a left pneumonectomy (Table 2). Effect of Pneumonectomy on Cardiac Function
Eighty-eight patients had measurable tricuspid regurgita-
tion by echocardiography, and the mean SPAP was 36  9
mm Hg assuming a right atrial pressure of 5 mm Hg. On the
basis of previously reported normal values, pulmonary
hypertension was present in 32 of 88 patients (36%), the110
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FIGURE 4. Correlation between preoperative and postoperative FEV1.
FEV1, Forced expiratory volume in second.
The Journal of Thoracic and Cpressures being mildly (SPAP 36–50 mm Hg) and moder-
ately (SPAP of 50–60 mmHg) elevated in 25 and 7 patients,
respectively. In 5 of these patients, pulmonary hypertension
was attributed to systolic left ventricular dysfunction or el-
evated left ventricle filling pressures. Patients with pulmo-
nary hypertension were older (72  7 years vs 67  10
years, P ¼ .02) and more likely to have had a left10
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FIGURE 5. Mean postoperative FEV1 in percent of predicted value in re-
lation to the importance of hyperinflation of the remaining lung and side of
pneumonectomy. *P<.01, **P<.05 compared with 76%–100% hyper-
inflation. FEV1, Forced expiratory volume in second.
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Spneumonectomy (SPAP of 39  9 mm Hg for left pneumo-
nectomy, SPAP of 32 8mmHg for right pneumonectomy,
P< .01). Left pneumonectomy was also associated with
a slightly lower left ventricular ejected fraction (59  10
vs 64  9, P<.01). The right ventricular index of myocar-
dial performance, which is a marker of systolic and diastolic
right ventricular function, was 0.40  18 (normal¼ 0.39
0.05) and, as expected, higher for patients with pulmonary
hypertension than in those without (0.51  0.16 vs 0.36 
17, P<.01). Pulmonary hypertension was not associated
with significant differences in pulmonary function, lung hy-
perinflation, blood gas values, cardiac output, and 6-MWT
(Table 3).
DISCUSSION
Although lobectomy is the surgical standard of care for
the management of early-stage lung cancer, pneumonec-
tomy is sometimes the only option to completely resect cen-
trally located or high-stage tumors. This operation is
known, however, to be associated with significantly higher
operative mortality19 and worse functional outcomes with
deterioration of cardiopulmonary function overtime. Unfor-
tunately the magnitude of this deterioration in long-term
survivors is not well known even if such information would
be relevant to any surgeon recommending pneumonectomy
or any patient who will have to live with only 1 lung for the
rest of his or her days.
Even if sources of dyspnea can be several in patients un-
dergoing pneumonectomy, this symptom is still the princi-
pal clinical manifestation of lung function impairment. It
is interesting to note that in our cohort, most patients
were not severely handicapped by dyspnea and that breath-
lessness was not a limiting factor for the performance of
normal activities. In agreement with previous reports on
the postpneumonectomy state,11 the loss of expiratory
lung volumes (FEV1, FVC) was in the range of 30%,
with a proportionally greater loss occurring after right pneu-
monectomy than after left pneumonectomy (Table 2).TABLE 3. Consequences of pulmonary hypertension on cardiopul-
monary function
Pulmonary
hypertension
(N ¼ 32)
No pulmonary
hypertension
(N ¼ 56) P value
FEV1 (liters) 1.46  0.33 1.51  0.41 .57
DLCO (% of predicted) 57  10 59  3 .32
PAO2 (mm Hg) 85  9 89  10 .08
6-MWD (meters) 384  75 411  92 .19
6-MWD (% of predicted) 84  16 83  17 .66
Cardiac output (L/min) 4.19  0.84 4.16  0.76 .86
RIMP 0.51  0.16 0.36  0.17 <.01
FEV1, Forced expiratory volume in 1 second; DLCO, carbon monoxide diffusing ca-
pacity; 6-MWD, 6-minute walk distance; RIMP, right ventricular index of myocardiac
performance.
12 The Journal of Thoracic and Cardiovascular SurgeDespite this loss, the mean postoperative FEV1 was still
1.46  0.39 liters. There was a significant correlation
between preoperative and postoperative FEV1, but the
wide range of variance among subjects suggests that it
would be difficult to accurately predict the long-term post-
operative FEV1 of a given patient on the basis of preopera-
tive value and side of operation.
Hyperinflation of the remaining lung, described as ‘‘vi-
carious emphysema’’ by Birath and colleagues3 in 1947,
has been the subject of speculation as to whether it leads
to true emphysema with rupture of alveolar septa and
lung destruction, in which case it should be prevented by
not allowing mediastinal displacement, or represents simple
lung enlargement without destruction, in which case it
would be beneficial.7 Although the quantification of hyper-
inflation by chest radiography may have some limitation,
our analysis suggests that more hyperinflation correlates
with better FEV1, and thus has a beneficial effect on postop-
erative lung function. This may be explained by the in-
creased radial traction on small airways that results from
hyperinflation and contributes to lower airway resistance
and improve expiratory airflow.
After pneumonectomy, DLCO has generally been re-
ported to be low,5,6,10 a finding that is in keeping with the
dependence of this measurement on the exchange surface
available for gas transfer, but still high with respect to
having only 1 lung.8 Hsia and colleagues20 further showed
that the ability to recruit DLCO during exercise after pneu-
monectomy constitutes an important feature that prevents
significant arterial desaturation. Our findings that DLCO
is reduced by 33%  18% of predicted values but still
remains above what is expected for only 1 lung and that
arterial blood gases are normal at rest indicate that
gas transfer in the remaining lung is normal after pneumo-
nectomy.
Because pneumonectomy is associated with a reduction
of ventilatory and diffusing capacities, as well as a possible
reduction in maximal cardiac output, patients are expected
to be limited in their exercise capacity.9 Indeed, previous
studies10,21,22 have documented a reduction of maximal
oxygen uptake ranging from 16% to 30%. In one study
in which exercise capacity was measured before and after
pneumonectomy in 13 patients,21 the mean decrease in
maximal oxygen uptake was 6.72 mL/min/kg, and the in-
vestigators commented that the impaired exercise perfor-
mance was perhaps not as much as expected. In this
project, we assessed exercise tolerance and functional ca-
pacity with the 6-MWT, which is less stressful than exercis-
ing on a bicycle ergometer while still providing simple,
practical, and objective measurements of disability on per-
forming everyday physical activities. The results (83% 
17% of predicted value) suggest that most patients long
term after pneumonectomy do not have significant impair-
ment of their exercise tolerance.ry c January 2011
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nificant increase in blood flow through the remaining lung
and an increase in pulmonary vascular resistance, and that
these factors can ultimately lead to pulmonary hypertension
and depression of right ventricle function. In the past, these
changes were studied by right-sided heart catheteriza-
tion,5,10 but currently, Doppler echocardiography has been
shown to be accurate and less invasive than heart
catheterization for the estimation of right-sided heart pres-
sures and right ventricular performances.23-25 In one
study,25 in which SPAP was evaluated with Doppler echo-
cardiography preoperatively and up to 4 years postopera-
tively, its value increased from 26  3 mm Hg before
operation to 34  8 mm Hg (P< .01) postoperatively.
The authors concluded that even if the increase in SPAP
was significant, it still did not elicit hypertrophy of the right
ventricle free wall. In the present study, the mean SPAP was
36 9 mmHg and there were no cases of severe pulmonary
hypertension. As expected, SPAP was related to patients’
age,18 but SPAP was also more elevated in patients who
had a left pneumonectomy than in those who had a right
pneumonectomy. This observation should, however, be in-
terpreted with caution because pulmonary vascular param-
eters were not assessed preoperatively. In addition, these
results may be related to differences in baseline characteris-
tics of patients who underwent pneumonectomy. As sug-
gested by the patients’ lower postoperative left ventricular
ejection fraction, we may have been more liberal in our se-
lection of patients who were scheduled for left pneumonec-
tomy than we were for those who were scheduled for right
pneumonectomy. Other explanations may include differ-
ences in mediastinal shift resulting in differential hemody-
namic changes or echocardiographic accuracy. Most
important, pulmonary hypertension, when present, had no
significant repercussions on pulmonary function (FEV1),
gas exchange (PAO2, PACO2), cardiac output, and exercise
tolerance as measured by the 6-MWT (Table 3).
It should be emphasized that this study population as-
sessed 5 or more years after pneumonectomy may not be
a random sample of the original cohort and that despite sim-
ilar baseline demographics, lung function, and cancer stage
(pTNM), differences may still exist between survivors and
patients who died. As such, the observed cardiorespiratory
adjustments may not be the same as if the whole original co-
hort were evaluated within the same interval between oper-
ation and study time. In addition, subjective functional
impairment assessed by the ATS questionnaire may under-
estimate the level of dyspnea because of a ‘‘survivor effect,’’
resulting from symptom minimization by patients grateful
of being cured from lung cancer. Although lung function
and pulmonary artery pressure were not related to time
elapsed since surgery, the present study does not allow the
drawing of conclusions or the time course of cardiopulmo-
nary adjustments.The Journal of Thoracic and CCONCLUSIONS
Our data indicate that the long-term adjustments that fol-
low pneumonectomy lead to a worsening of expiratory lung
volumes by 30%, but that hyperinflation is beneficial to
overall lung function and pulmonary hypertension is un-
common. Despite the loss of expiratory volume, patients
still have normal gas exchange and exercise capacity, and
thus most are able to lead a near normal life. Late cardiopul-
monary insufficiency related to negative physiologic conse-
quences is uncommon.
The authors thank Debbie R. Deslauriers and Sylvie Martin,
research assistants, for invaluable technical assistance during the
conduct of the study.
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Dr David Sugarbaker (Boston, Mass). This study represents
the first comprehensive evaluation of patients at a relatively long
term after pneumonectomy. It demonstrates clearly that pneumo-
nectomy can be a lifesaving procedure and that these patients
can enjoy relatively normal physiology and presumably quality
of life at a significant time period after resection.
This study attempts to evaluate several factors that are impor-
tant in producing long-term cardiopulmonary function. I’d like
to congratulate Dr Deslauriers and his group on completing a study
that I think is long overdue. These results are interesting and may
have a significant impact on the selection and evaluation of pa-
tients who are considered for pneumonectomy for a variety of rea-
sons, and here for oncologic reasons.
I have3questions. First, in light of your finding that compensatory
hyperinflation is present and that it has potential beneficial effects in
the patient postpneumonectomy—and I think that’s certainly my
clinical intuition, that seeing patients doing well with a significant
mediastinal shift, those 2 often go together, as long as there is not ob-
struction of the airway and this physiologic compensation is benefi-
cial—given this finding that you have clearly demonstrated, can you
comment on the conventional use of preoperative quantitative V/Q
scanning to predict postoperative FEV1, particularly in light of this
confounding hyperinflation and your data that showed only a 15%
to 30% overall reduction in FEV1?
Dr Deslauriers. Preoperative V/Q scans are useful to predict
short-term post-resectional function but are probably less reliable
to predict long-term function because late physiologic adjust-
ments, such as hyperinflation, mediastinal shift, and diaphragmatic
function, are not taken into account by these scans.
Dr Sugarbaker. I think your study shows that the human phys-
iology is amazingly compensatory and that quantitative V/Q scans
may not have all the answers.
Number 2, what impact do you think this study has on the con-
ventional criteria for patient selection, which were obviously used
in this group. I presume the initial criteria were conventional, and
do you think this study will have any impact on what we should
evaluate before contemplating pneumonectomy?
DrDeslauriers.Although pneumonectomies carry a significant
risk of operative mortality, the fact that most survivors are able to
successfully adjust to living with only 1 lung is remarkable. I am
not sure, however, that these results will change our selection cri-
teria, but they will certainly provide reasonable answers to patients
who are anxious about quality of life, exercise tolerance, and level
of dyspnea after this operation.14 The Journal of Thoracic and Cardiovascular SurgeDr Sugarbaker. I have a final question. This study was able to
find 117 patients living at least 5 years from an initial cohort of 523
patients whom you nicely outlined. I think if you corrected it for
the patients in stage II and III whom you presented, the survival
would be well below 20% 5-year survival. In light of that, could
you address the observation that these results in terms of function-
ality may not be applicable to the patients who lived 2 or 3 years?
Also, I would say that the survival here is sort of approaching that
for extrapleural pneumonectomy and meso, which is approxi-
mately 15% to 20% at 5 years, and you just wonder whether the
earlier physiology has self-selected those patients out of this and
they have died beforehand, although you point out that 5% of
deaths were cardiac.
DrDeslauriers.The overall 5-year survival for the entire cohort
of 523 patients was 31.4% and 81% of patients included in this
study had stage 2 and 3 disease. When we carefully analyze the
cause of death of the 406 patients who died during the interval, it
was interesting to note that the majority had cancer-related deaths
sometimes more than 5 years after the operation and that few died
of respiratory failure. This information certainly suggests that the
results of this study would be applicable to patients who live for
only 2 to 3 years postoperatively as long as they are free of disease.
Dr Sugarbaker. This is an excellent study, Dr Deslauriers. Your
group is to be congratulated.
Dr Dominique Grunenwald (Paris, France). I congratulate
you, Jean, for rehabilitating pneumonectomy after spending years
defending sleeve lobectomies to precisely avoid pneumonectomy.
Nevertheless, it was an excellent article. In my opinion, it is
encouraging, this 30% loss of respiratory function, to open the
way for proposing surgical resections for the second primaries,
metachronous disease, in a residual lung in the long term after
a pneumonectomy.
My question is, did you look at the difference between the left
and the right side because of the difference of volumes of the
lungs?
DrDeslauriers.We did look at respiratory function after left and
right pneumonectomies, and other than for losses in expiratory vol-
umes, which were higher after right pneumonectomy than after left,
there were no significant differences in all other parameters of lung
function whether the patient had a right or left pneumonectomy.
Dr Federico Venuta (Rome, Italy). This is a large number of
patients. Were you able to stratify the cardiac performance of these
patients according to the FEV1? Our experience is that the pneu-
monectomy population overall has good results in terms of heart
function, but if you go down with the FEV1, in the long run, at least
in our experience, they develop a significant degree of pulmonary
hypertension and heart failure, and after 5 years, most of the pa-
tients with lower values of FEV1 are in this category.
Dr Deslauriers.Youmean correlate FEV1 with the level of pul-
monary hypertension.
Dr Venuta. Yes. It was high. It was approximately 90%. It was
87%, the preoperative FEV1.
Dr Deslauriers. In this series, there were no significant differ-
ences in pulmonary function (FEV1), DLCO, PAO2, and 6-minute
walk distance, whether the patient had pulmonary hypertension
or not.
Dr Paul Van Schil (Antwerp, Belgium). I would like to come
back to the drainage of the pneumonectomy space. I rememberry c January 2011
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Ssome earlier work of yours stating that when you use a balanced
pneumonectomy drainage system, the incidence of postpneumo-
nectomy acute respiratory distress syndrome decreases. What is
your current policy and could this influence the long-term results
regarding respiratory function?
Dr Deslauriers. Since we looked at this problem some years
ago and determined that water seal drainage of the pneumonec-
tomy space was a risk factor for postpneumonectomy edema
caused by rapid overdistention of the remaining lung, I do not drain
the pneumonectomy space. But once the chest wall is closed, I re-
move 1000 mL of air to balance the mediastinum. I do not think,
however, that the method used to handle the pneumonectomy
space in the acute setting has much to do with long-term results
of pulmonary function.
Dr Nasser Altorki (New York, NY). It’s easy to understand the
changes in FEV1 being 33%. You know, you get adjustments in the
small airway mechanics and the chest wall mechanics. What I
don’t understand is your DLCO number, an 18% reduction inThe Journal of Thoracic and Cthe DLCO. I wonder if you have insight into that. There are a lot
of basic researchers in our institutions who are interested in the
concept of pulmonary regeneration, alveolar regeneration. I’m
not suggesting that is going on, but do you have any insight into it?
Dr Deslauriers. I do not really have an insight as to why the
value of DLCO is higher than it should be for only 1 lung, but
the same observations have been made by other investigators. It
certainly indicates that gas transfer is normal, and perhaps there
is a greater exchange surface available because of hyperinflation
of the remaining lung.
DrAltorki.But you are not going to do that with a fixed number
of alveolar spaces. Something has to happen at the alveolar level,
at the gas exchange level.
Dr Deslauriers. I do not have a specific answer to your ques-
tion.
Dr Altorki. Well, I think what you show is true. I’m intrigued
by the explanation. I think we have to learn more about that.
Dr Deslauriers. Thank you for your comments.ardiovascular Surgery c Volume 141, Number 1 15
